1-1 of 1
Stilgenbauer Stephan
Close
Save search
Sort by
Journal Articles

TPLL-1 Protocol of the German CLL Study Group (GCLLSG) - A Prospective Phase II Trial of Fludarabine Phosphate, Mitoxantrone and Cyclophosphamide (FMC) Followed by Alemtuzumab Consolidation in T-PLL.

Free
Georg Hopfinger, MD, Raymonde Busch, PD, Eichhorst Barbara, MD, Cramer Paula, MD, Kandler Gabriele, MD, Fingerle-Rowson Gunther, MD, Fink Anna-Maria, MD, Stilgenbauer Stephan, MD, Hallek Michael, MD
Journal: Blood
Blood (2007) 110 (11): 2039.
https://doi.org/10.1182/blood.V110.11.2039.2039
Published: 2007